Literature DB >> 24951945

Pharmacists in pharmacovigilance: can increased diagnostic opportunity in community settings translate to better vigilance?

Paul Rutter1, David Brown, Justine Howard, Christine Randall.   

Abstract

The pharmacy profession has undergone substantial change over the last two to three decades. Whilst medicine supply still remains a central function, pharmacist's roles and responsibilities have become more clinic and patient focused. In the community (primary care), pharmacists have become important providers of healthcare as Western healthcare policy advocates patient self-care. This has resulted in pharmacists taking on greater responsibility in managing minor illness and the delivery of public health interventions. These roles require pharmacists to more fully use their clinical skills, and often involve diagnosis and therapeutic management. Community pharmacists are now, more than ever before, in a position to identify, record and report medication safety incidents. However, current research suggests that diagnostic ability of community pharmacists is questionable and they infrequently report to local or national schemes. The aim of this paper is to highlight current practice and suggest ways in which community pharmacy can more fully contribute to patient safety.

Entities:  

Mesh:

Year:  2014        PMID: 24951945     DOI: 10.1007/s40264-014-0191-6

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  27 in total

1.  Pharmacists' role in reporting adverse drug reactions in an international perspective.

Authors:  Kees van Grootheest; Sten Olsson; Mary Couper; Lolkje de Jong-van den Berg
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-07       Impact factor: 2.890

Review 2.  Review of services provided by pharmacies that promote healthy living.

Authors:  David Brown; Jane Portlock; Paul Rutter
Journal:  Int J Clin Pharm       Date:  2012-04-17

3.  Community pharmacy: moving from dispensing to diagnosis and treatment.

Authors:  Elizabeth Richardson; Allyson M Pollock
Journal:  BMJ       Date:  2010-05-11

4.  Ontario Pharmaceutical Opinion Program: Initial experience.

Authors:  Bryan Gray
Journal:  Can Pharm J (Ott)       Date:  2013-11

5.  Pharmacy students' knowledge and perceptions about pharmacovigilance in Malaysian public universities.

Authors:  Ramadan Mohamed Elkalmi; Mohamed Azmi Hassali; Mohamed Izham M Ibrahim; Riyanto T Widodo; Qais M A Efan; Muhammad Abdul Hadi
Journal:  Am J Pharm Educ       Date:  2011-06-10       Impact factor: 2.047

6.  Pharmacist reporting of serious adverse drug events to the Food and Drug Administration.

Authors:  Paul Gavaza; Carolyn M Brown; Kenneth A Lawson; Karen L Rascati; Mary Steinhardt; James P Wilson
Journal:  J Am Pharm Assoc (2003)       Date:  2012 Sep-Oct

Review 7.  Pharmacists and prescribing rights: review of international developments.

Authors:  Lynne Emmerton; Jennifer Marriott; Tracey Bessell; Lisa Nissen; Laura Dean
Journal:  J Pharm Pharm Sci       Date:  2005-08-04       Impact factor: 2.327

8.  Evaluation of community pharmacists' recommendations to standardized patient scenarios.

Authors:  Paul M Rutter; Emma Horsley; David T Brown
Journal:  Ann Pharmacother       Date:  2004-04-27       Impact factor: 3.154

9.  A pilot study to evaluate a community pharmacy-based monitoring system to identify adverse drug reactions associated with paediatric medicines use.

Authors:  Mansour Tobaiqy; Derek Stewart; Peter J Helms; Christine Bond; Amanda Jane Lee; Nick Bateman; Dorothy McCaig; James McLay
Journal:  Eur J Clin Pharmacol       Date:  2010-03-02       Impact factor: 2.953

10.  Impact of pharmacist recruitment on ADR reporting: Malaysian experience.

Authors:  Muhammad Abdul Hadi; Long Chiau Ming
Journal:  South Med Rev       Date:  2011-12-02
View more
  5 in total

1.  Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand.

Authors:  Joanne Barnes; Rachael Butler
Journal:  Drug Saf       Date:  2020-11       Impact factor: 5.606

Review 2.  Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature.

Authors:  Michael Reumerman; J Tichelaar; B Piersma; M C Richir; M A van Agtmael
Journal:  Eur J Clin Pharmacol       Date:  2018-06-20       Impact factor: 2.953

3.  The Need to Strengthen the Role of the Pharmacist in Sri Lanka: Perspectives.

Authors:  M H F Sakeena; Alexandra A Bennett; Andrew J McLachlan
Journal:  Pharmacy (Basel)       Date:  2019-06-05

4.  Pharmacy students' knowledge and perceptions about adverse drug reactions reporting and pharmacovigilance.

Authors:  Kingston Rajiah; Mari Kannan Maharajan; Shashina Nair
Journal:  Saudi Pharm J       Date:  2015-03-23       Impact factor: 4.330

5.  Strengths and Weaknesses of the Pharmacovigilance Systems in Three Arab Countries: A Mixed-Methods Study Using the WHO Pharmacovigilance Indicators.

Authors:  Hamza Garashi; Douglas Steinke; Ellen Schafheutle
Journal:  Int J Environ Res Public Health       Date:  2022-02-22       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.